By Professor David Lawson Morris

Journal articles

Chua TC; Glenn DW; Morris DL, 2010, 'Extending the survival of patients with melanoma lung metastases through radiofrequency ablation', ACTA Oncologica, 49, pp. 517 - 519, http://dx.doi.org/10.3109/02841860903473305

Saxena A; Chua TC; Bester L; Kokandi A; Morris DL, 2010, 'Factors predicting response and survival after Yttrium-90 radioembolization of unresectable neuroendocrine tumor liver metastases: A critical appraisal of 48 cases', Annals of Surgery, 251, pp. 910 - 916, http://dx.doi.org/10.1097/SLA.0b013e3181d3d24a

Yao P; Stanton R; Chua TC; Wines MP; Gunasegaram A; Ladd LA; Morris DL, 2010, 'Hand-assisted laparoscopic partial nephrectomy: A controlled study of bipolar InLine radiofrequency ablation device in swine', Surgical Innovation, 17, pp. 57 - 62, http://dx.doi.org/10.1177/1553350609360354

Ding JH; Chua TC; Al-Mohaimeed K; Morris DL, 2010, 'Hepatocellular carcinoma peritoneal metastases: Report of three cases and collective review of the literature', Annals of Academy of Medicine Singapore, 39, pp. 734 - 737

Chua TC; Morris DL; Esquivel J, 2010, 'Impact of the peritoneal surface disease severity score on survival in patients with colorectal cancer peritoneal carcinomatosis undergoing complete cytoreduction and hyperthermic intraperitoneal chemotherapy', Annals of Surgical Oncology, 17, pp. 1330 - 1336, http://dx.doi.org/10.1245/s10434-009-0866-x

Chua TC; Yao P; Akhter J; Morris DL, 2010, 'Impact of tumor angiogenesis in peritoneal mesothelioma after radical cytoreduction and hyperthermic intraperitoneal chemotherapy', Pathology and Oncology Research, 16, pp. 217 - 222, http://dx.doi.org/10.1007/s12253-009-9210-9

Chua TC; Chu F; Butler P; Quinn RJ; Glenn DW; Liauw WS; Morris DL, 2010, 'Intra-arterial iodine-131-lipiodol for unresectable hepatocellular carcinoma', Cancer, 116, pp. 4069 - 4077, http://dx.doi.org/10.1002/cncr.25283

Chua TC; Sarkar A; Saxena A; Glenn DW; Zhao J; Morris DL, 2010, 'Long-term outcome of image-guided percutaneous radiofrequency ablation of lung metastases: an open-labeled prospective trial of 148 patients.', Annals of Oncology, 21, pp. 2017 - 2022, http://dx.doi.org/10.1093/annonc/mdq098

Chua TC; Saxena A; Schellekens J; Liauw WS; Yan TD; Fransi S; Zhao J; Morris DL, 2010, 'Morbidity and mortality outcomes of cytoreductive surgery and perioperative intraperitoneal chemotherapy at a single tertiary institution: Towards a new perspective of this treatment.', Annals of Surgical Oncology, 251, pp. 101 - 106, http://dx.doi.org/10.1097/SLA.0b013e3181b5ae43

Mekkawy AH; De Bock CE; Lin Z; Morris DL; Wang Y; Pourgholami MH, 2010, 'Novel protein interactors of urokinase-type plasminogen activator receptor', Biochemical and Biophysical Research Communications, 399, pp. 738 - 743, http://dx.doi.org/10.1016/j.bbrc.2010.08.010

Chua TC; Yan TD; Zhao J; Morris DL, 2010, 'Palliative effects of an incomplete cytoreduction combined with perioperative intraperitoneal chemotherapy', American Journal of Clinical Oncology - Cancer Clinical Trials, 33, pp. 568 - 571, http://dx.doi.org/10.1097/COC.0b013e3181b9cf47

Pourgholami MH; Szwajcer ; Chin MTM; Liauw WS; Szwajcer ; Galettis P; Morris DL; Links MJ, 2010, 'Phase I clinical trial to determine maximum tolerated dose of oral albendazole in patients with advanced cancer', Cancer Chemotherapy and Pharmacology, 65, pp. 597 - 605, http://dx.doi.org/10.107/s00280-009-1157-8

Saxena A; Chua TC; Yan TD; Morris DL, 2010, 'Postoperative pancreatic fistula after cytoreductive surgery and perioperative intraperitoneal chemotherapy: Incidence, risk factors, management, and clinical sequelae', Annals of Surgical Oncology, 17, pp. 1302 - 1310, http://dx.doi.org/10.1245/s10434-009-0898-2

Pourgholami MH; Cai YZ; Badar S; Wangoo K; Poruchynsky MS; Morris DL, 2010, 'Potent inhibition of tumoral hypoxia-inducible factor 1á by albendazole.', BMC Cancer, 10:143, pp. 1 - 7, http://dx.doi.org/10.1186/1471-2407-10-143

Cao C; Yan TD; Bester L; Liauw WS; Morris DL, 2010, 'Radioembolization with yttrium micropheres for neuroendocrine tumour liver metastases', British Journal of Surgery, 97, pp. 537 - 543, http://dx.doi.org/10.1002/bjs.6931

Cao C; Yan TD; Morris DL; Bester L, 2010, 'Radioembolization with yttrium-90 microspheres for pancreatic cancer liver metastases: results from a pilot study', Tumori, 96, pp. 955 - 958

Chua TC; Thornbury K; Saxena A; Liauw WS; Glenn DW; Zhao J; Morris DL, 2010, 'Radiofrequency ablation as an adjunct to systemic chemotherapy for colorectal pulmonary metastases', Cancer, 116, pp. 2106 - 2114, http://dx.doi.org/10.1002/cncr.24952

Tudor E; Chua TC; Liauw WS; Morris DL, 2010, 'Risk factors and clinicopathological study of prognostic factors in the peritoneal mesothelioma.', American Surgeon, 76, pp. 400 - 405

Chua TC; Robertson G; Liauw WS; Morris DL, 2010, 'Salvage cytoreduction for chemorefractory ovarian cancer with peritoneal carcinomatosis: A last chance or futile efforts?', Australian and New Zealand Journal of Obstetrics and Gynaecology, 50, pp. 478 - 484, http://dx.doi.org/10.1111/j.1479-828X.2010.01201.x

Chua TC; Liauw WS; Robertson G; Morris DL, 2010, 'Second-line treatment of first relapse recurrent ovarian cancer', Australian and New Zealand Journal of Obstetrics and Gynaecology, 50, pp. 465 - 471, http://dx.doi.org/10.1111/j.1479-828X.2010.01209.x

Chua TC; Al-Zahrani A; Saxena A; Liauw WS; Zhao J; Morris DL, 2010, 'Secondary cytoreduction and perioperative intraperitoneal chemotherapy after initial debulking of pseudomyxoma peritonei: A study of timing and the impact of malignant dedifferentiation.', Journal of the American College of Surgeons, 211, pp. 526 - 535, http://dx.doi.org/10.1016/j.jamcollsurg.2010.06.011

Chua TC; Bester L; Akhter J; Morris DL, 2010, 'Successful right hepatectomy after four treatments of yttrium-90 microspheres (SIR-Spheres (R)) and concomitant FOLFOX as bridging therapy to resection of colorectal liver metastases.', Anticancer Research, 30, pp. 3005 - 3008

Chua TC; Saxena A; Morris DL, 2010, 'Surgical metastasectomy in AJCC stage IV M1c melanoma patients with gastrointestinal and liver metastases', Annals of Academy of Medicine Singapore, 39, pp. 634 - 639

evans KJ; Richardson M; Pavlakis N; Morris DL; Liauw WS; Bester L, 2010, 'Survival outcomes of a salvage patient population after radioembolization of hepatic metastases with yttrium-90 microspheres', Journal of Vascular and Interventional Radiology, 21, pp. 1521 - 1526, http://dx.doi.org/10.1016/j.jvir.2010.06.018

Chua TC; Liauw WS; Saxena A; Chu F; Glenn DW; Chai A; Morris DL, 2010, 'Systematic review of neoadjuvant transarterial chemoembolization for resectable hepatocellular carcinoma', Liver International, 30, pp. 166 - 174, http://dx.doi.org/10.1111/j.1478-3231.2009.02166.x

Chua TC; Saxena A; Liauw WS; Kokandi A; Morris DL, 2010, 'Systematic review of randomized and nonrandomized trials of the clinical response and outcomes of neoadjuvant systemic chemotherapy for resectable colorectal liver metastases', Annals of Surgical Oncology, 17, pp. 492 - 501, http://dx.doi.org/10.1245/s10434-009-0781-1

Pourgholami MH; Cai YZ; Chu SW; Galettis P; Morris DL, 2010, 'The influence of ovarian cancer induced peritoneal carcinomatosis on the pharmacokinetics of albendazole in nude mice.', Anticancer Research, 30, pp. 423 - 428

Morris DL; Chua TC, 2010, 'Treatments and outcomes of peritoneal surface tumors through a Centralized National Service (United Kingdom)', Diseases of the Colon and Rectum, 53, pp. 1218 - 1219, http://dx.doi.org/10.1007/DCR.0b013e318e28bcf

Saxena A; Bester L; Chua TC; Chu F; Morris DL, 2010, 'Yttrium-90 radiotherapy for unresectable intrahepatic cholangiocarcinoma: a preliminary assessment of this novel treatment option', Annals of Surgical Oncology, 17, pp. 484 - 491, http://dx.doi.org/10.1245/s10434-009-0777-x

Shehata M; Yan K; Itoh S; King J; Glenn D; Quinn R; Morris DL, 2009, 'Splenomegaly and tumor marker response following selective internal radiation therapy for non-resectable liver metastases from neuroendocrine tumor', Dokkyo Journal of Medical Sciences, 36, pp. 131 - 134

Patyna S; Haznedar J; Morris D; Freshwater K; Peng G; Sukbuntherng J; Chmielewski G; Matsumoto D, 2009, 'Evaluation of the safety and pharmacokinetics of the multi-targeted receptor tyrosine kinase inhibitor sunitinib during embryo-fetal development in rats and rabbits', Birth Defects Research Part B - Developmental and Reproductive Toxicology, 86, pp. 204 - 213, http://dx.doi.org/10.1002/bdrb.20194

Chua TC; Robertson G; Farrell R; Liauw W; Yan TD; Morris DL, 2009, 'Systematic review of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for ovarian peritoneal carcinomatosis: A more efficacious way of delivering intraperitoneal chemotherapy', Journal of Clinical Oncology, http://dx.doi.org/10.1200/jco.2009.27.15_suppl.5524

Chua TC; Yao P; Akther J; Bao S; Young L; Yan TD; Samaraweera U; Morris DL, 2009, 'Differential expression of Ki-67, estrogen receptor and progesterone receptor between genders in peritoneal mesothelioma', ANNALS OF SURGICAL ONCOLOGY, 16, pp. 32 - 32, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000207857400095&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Cao C; Yan TD; Black DA; Morris DL, 2009, 'A systematic review and meta-analysis of cytoreductive surgery with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal origin', Annals of Surgical Oncology, 16, pp. 2152 - 2165, http://dx.doi.org/10.1245/s10434-009-0487-4

Cao C; Yan TD; Liauw WS; Morris DL, 2009, 'Comparison of optimally resected hepatectomy and peritonectomy patients with colorectal cancer metastasis', Journal of Surgical Oncology, 100, pp. 529 - 533, http://dx.doi.org/10.1002/jso.21369

Chua TC; Pelz J; Kerscher A; Morris DL; Esquivel J, 2009, 'Critical Analysis of 33 Patients with Peritoneal Carcinomatosis Secondary to Colorectal and Appendiceal Signet Ring Cell Carcinoma', Annals of Surgical Oncology, 16, pp. 2765 - 2770

Yan TD; Deraco M; Baratti D; Kusamura S; Elias D; Glehen O; Gilly F; Levine E; Shen P; Mohamed F; Moran B; Morris DL; Chua TC; Piso P; Sugarbaker PH, 2009, 'Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: Multi-institutional experience', Journal of Clinical Oncology, 27, pp. 6237 - 6242, http://dx.doi.org/10.1200/JCO.2009.23.9640

Chua TC; Koh J; Yan TD; Liauw WS; Morris DL, 2009, 'Cytoreductive surgey and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from small bowel adenocarcinoma', Journal of Surgical Oncology, 100, pp. 139 - 143, http://dx.doi.org/10.1002/jso.21315

Chua T; Yao P; Young L; Akhter J; Bao S; samaraweera U; Yan TD; Morris DL, 2009, 'Differential expression of Ki-67 and sex steroid hormone receptors between genders in peritoneal mesothelioma', Pathology and Oncology Research, 15, pp. 671 - 678, http://dx.doi.org/10.1007/s12253-009-9170-0

Chua TC; Liauw WS; Robertson G; Morris DL, 2009, 'Establishing evidence for change in ovarian cancer surgery - proposing clinical trials of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer peritoneal carcinomatosis', Gynecologic Oncology, 115, pp. 166 - 168, http://dx.doi.org/10.1016/j.ygyno.2009.06.010

Koh J; Yan TD; Glenn DW; Morris DL, 2009, 'Evaluation of preoperative computed tomography in estimating peritoneal cancer index in colorectal peritoneal carcinomatosis', Annals of Surgical Oncology, 16, pp. 327 - 333, http://dx.doi.org/10.1245/s10434-008-0234-2

Haghighi K; Glenn DW; Gruenberger T; Morris DL, 2009, 'Extending the limits for curative liver resections by portal vein embolisation', International Surgery, 94, pp. 43 - 47

Ding JH; Chua TC; Glenn DW; Morris DL, 2009, 'Feasibility of ablation as an alternative to surgical metastasectomy in patients with unresectable sarcoma pulmonary metastases', Interactive Cardiovascular and Thoracic Surgery, 9, pp. 1051 - 1053, http://dx.doi.org/10.1510/icvts.2009.218743

Chua TC; Akhter J; Yao P; Morris DL, 2009, 'In vivo model of pseudomyxoma peritonei for novel candidate drug discovery', Anticancer Research, 29, pp. 4051 - 4055

Pourgholami MH; Cai ZY; Wang L; Badar S; Links MJ; Morris DL, 2009, 'Inhibition of cell proliferation, vascular endothelial growth factor and tumor growth by albendazole', Cancer Investigation, 27, pp. 171 - 177, http://dx.doi.org/10.1080/07357900802210752

Chua TC; Robertson G; Liauw WS; Farrell R; Yan TD; Morris DL, 2009, 'Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery in ovarian cancer peritoneal carcinomatosis: systematic review of current results', Journal of Cancer Research and Clinical Oncology, 135, pp. 1637 - 1645, http://dx.doi.org/10.1007/s00432-009-0667-4

Chua TC; Yan TD; Smigielski ME; Zhu K; Ng K; Zhao J; Morris DL, 2009, 'Long-term survival in patients with pseudomyxoma peritonei treated with cytoreductive surgery and perioperative intraperitoneal chemotherapy: 10 years experience from a single institution', Annals of Surgical Oncology, 16, pp. 1903 - 1911, http://dx.doi.org/10.1245/s10434-009-0341-8

Chua TC; Liauw WS; Morris DL, 2009, 'New treatments and outcomes in peritoneal carcinomatosis', Medical Journal of Australia, 191, pp. 3 - 4

Chua TC; Yan TD; Morris DL, 2009, 'Outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: The Australian Experience', Journal of Surgical Oncology, 99, pp. 109 - 113, http://dx.doi.org/10.1002/jso.21177

Chua TC; Yan TD; Zhao J; Morris DL, 2009, 'Peritoneal carcinomatosis and liver metastases from colorectal cancer treated with cytoreductive surgery perioperative intraperitoneal chemotherapy and liver resection', European Journal of Surgical Oncology, 35, pp. 1299 - 1305, http://dx.doi.org/10.1016/j.ejso.2009.07.005

Back to profile page